Outcomes of COVID-19 infection in patients on dialysis and kidney transplant recipients: A single-centre audit

Abstract

Patients with end-stage kidney disease (ESKD) are at increased risk of adverse outcomes following COVID-19 infection. Their vulnerability stems from multiple factors including kidney failure, comorbid illnesses, close contact in the haemodialysis centre, and transplant immunosuppression. European registry data in the pre-vaccination era report a COVID-19 mortality rate of 20% among patients on dialysis and 19.9% in kidney transplant recipients, with transplant recipients having 1.28 times the mortality risk of matched dialysis patients.1 More recent studies have reported mortality rates of 7–20% among vaccinated patients on dialysis or transplant recipients.2–4